ABG-WTT Global Life Science Capital Partners GP Ltd
•CIK: 1832108•Filing: Q4 2025
**ABG-WTT Global Life Science Capital Partners GP Ltd** manages a focused $15M AUM, targeting high-growth opportunities within the global life science sector. The fund maintains a concentrated portfolio of two key positions, with CBLL representing the largest holding at $9.7M. This allocation suggests a strategic conviction in CBLL's near-term catalysts, supplemented by a significant $5.4M position in RPID. The current structure indicates a deep, specialized commitment to select, high-potential biopharma assets.
Total AUM
$15.0M
QoQ Performance
-19.4%
Positions
2
Top 10 Concentration
100.0%
Latest Filing
Q4 2025
Top Holdings Allocation
CBLL
RPID
CBLL64.4%
RPID35.6%
📈 Biggest Buys
No new positions or increases this quarter
📉 Biggest Sells
CBLL
CERIBELL INC
-59.4%
64.4% of portfolio
Sector Breakdown
Other100.0%
Changes from Q3 2025
↓1 decreased
Historical Filings
Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023